Blog

Dec 16, 2024, 17:18

Rahul Banerjee: Antibody targets in smoldering multiple myeloma analyzed

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X:

“Fascinating analysis in HemaSphere Journal by Hermouet Sigurdur Kristinsson et al. – what is the antibody in smoldering multiple myeloma?

Unknown in a third of cases, but often targeting infection. A fascinating what-if question in the concluding paragraph below pertinent to all plasma cell disorders.”

Rahul Banerjee is an assistant professor at Fred Hutchinson Cancer Center at the University of Washington. He completed his residency at the University of Pennsylvania health system.

He completed his fellowship in haematology and oncology from the University of California, San Francisco. He has authored over 70 peer-reviewed publications. His clinical interests include multiple myeloma.

antibody targets cancer Hemasphere EHA hematologic malignancies hematology research Hermouet infection triggers multiple myeloma OncoDaily Oncology oncology research plasma cell disorders Rahul Banerjee Sigurdur Kristinsson Smoldering multiple myeloma Sykristinsson

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

Special Coverage